Cytek Biosciences (CTKB) EBIT Margin Growth (3y) (2023 - 2026)
Powered by 
Analysis
Cytek Biosciences (CTKB) EBIT Margin Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 224.92 Bn | 220.85 Bn | 8.34 Bn | 263.00 |
| 2 | Danaher | 144.72 Bn | 140.37 Bn | 3.61 Bn | -168.00 |
| 3 | Agilent Technologies | 41.07 Bn | 39.31 Bn | 1.04 Bn | 1,569.00 |
| 4 | Illumina | 31.27 Bn | 30.10 Bn | 770.00 Mn | 2,862.00 |
| 5 | Revvity | 13.85 Bn | 12.82 Bn | 416.87 Mn | 123.00 |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | -825.00 |
| 7 | Bio-Rad Laboratories | 10.14 Bn | 8.52 Bn | 345.80 Mn | -201.00 |
| 8 | Repligen | 9.32 Bn | 8.31 Bn | 110.04 Mn | -527.00 |
| 9 | 10x Genomics | 8.65 Bn | 8.10 Bn | 112.50 Mn | 3,021.00 |
| 10 | Cytek Biosciences | 611.05 Mn | 537.21 Mn | 28.34 Mn | -531.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -531.00 |
| Mar 31, 2026 | -904.00 |
| Dec 31, 2025 | -918.00 |
| Sep 30, 2025 | -2,094.00 |
| Jun 30, 2025 | -2,108.00 |
| Mar 31, 2025 | -2,940.00 |
| Dec 31, 2024 | 181.00 |
| Sep 30, 2024 | -1,668.00 |
| Jun 30, 2024 | -3,082.00 |
| Mar 31, 2024 | -2,859.00 |
| Dec 31, 2023 | -2,596.00 |
| Sep 30, 2023 | -4,012.00 |
| Jun 30, 2023 | -1,723.00 |